PCR6 The Association between Administration Method, Socio-Demographic Characteristics, and Patient-Reported Outcomes for Glucagon-like Peptide-1 Receptor Agonists Among Diabetes Patients in Japan: A Cross-Sectional Patient Survey

Abstract

In recent years, oral glucagon-like peptide-1 receptor agonist (GLP-1 RA) has become available. While an oral GLP-1 RA could simplify treatment compared to GLP-1 RA injections, it may also require an increase in administration frequency. This study examines the association between administration method (dosage form and administration frequency), socio-demographic characteristics, and patient-reported outcomes (PRO) under a real-world setting.